National results – Figures
- Figure 1.1 Trachoma prevalence in children aged 5-9 years in at-risk communities in Australia, 2013
- Figure 1.2 Number of communities at risk, by year and jurisdiction, Australia, 2007–2013
- Figure 1.3 Number of at-risk communities by jurisdiction, according to trachoma control strategy implemented, Australia, 2013
- Figure 1.4 Population screening coverage in children aged 5-9 years in communities that were screened for trachoma by jurisdiction, Australia, 2013
- Figure 1.5 Proportion of screened children aged 5-9 years who had a clean face, by year and jurisdiction, Australia, 2007–2013
- Figure 1.6 Trachoma prevalence among screened children aged 5-9 years, by year and jurisdiction, Australia, 2007–2013
- Figure 1.7 Number of screened at-risk communities according to level of trachoma prevalence in 5-9-year-old children, by jurisdiction, Australia, in 2013
- Figure 1.8 Number of communities according to number of years of trachoma prevalence under 5%, by jurisdiction in Australia, 2013
- Figure 1.9 Number of doses of azithromycin administered for the treatment of trachoma by jurisdiction in Australia, 2007–2013
National results –Tables
- Table 1.1 Trachoma control delivery in Australia in 2013
- Table 1.2 Trachoma screening coverage, trachoma prevalence and clean face prevalence in Australia in 2013
- Table 1.3 Treatment strategies by jurisdiction in Australia in 2013
- Table 1.4 Trachoma treatment coverage in Australia in 2013
- Table 1.5 Trichiasis screening coverage, prevalence and treatment among Aboriginal adults in Australia in 2013
National results – Figures
Figure 1.1 Trachoma prevalence in children aged 5-9 years in at-risk communities in Australia, 2013
Figure 1.2 Number of communities at risk, by year and jurisdiction, Australia, 2007–2013
* In 2013 NSW communities have been designated as “potentially at risk” for the purposes of a mapping exercise
Top of pageFigure 1.3 Number of at-risk communities by jurisdiction, according to trachoma control strategy implemented, Australia, 2013
Figure 1.4 Population screening coverage in children aged 5-9 years in communities that were screened for trachoma by jurisdiction, Australia, 2013
Figure 1.5 Proportion of screened children aged 5-9 years who had a clean face, by year and jurisdiction, Australia, 2007–2013
Figure 1.6 Trachoma prevalence among screened children* aged 5-9 years, by year and jurisdiction, Australia, 2007–2013
* Including communities in the Northern Territory that screened in 2013 and those that did not screen in 2013 in accordance with revised guideline instructions (see methodology)
Top of pageFigure 1.7 Number of screened at-risk communities* according to level of trachoma prevalence in 5-9-year-old children, by jurisdiction, Australia, in 2013
* Including communities in the Northern Territory that screened in 2013 and those that did not screen in 2013 in accordance with revised guideline instructions (see methodology)
Top of pageFigure 1.8 Number of communities according to number of years* of trachoma prevalence under 5%, by jurisdiction*† in Australia, 2013
* 5 years with a prevalence below 5% classifies a community as not at risk of trachoma
† Including communities in the Northern Territory that screened in 2013 and those that did not screen in 2013 in accordance with revised guideline instructions (see methodology)
Figure 1.9 Number of doses of azithromycin administered for the treatment of trachoma by jurisdiction in Australia, 2007–2013
National results –Tables
Number of communities |
Northern Territory |
South Australia |
Western Australia |
New South Wales |
Total |
Not at-risk |
---|---|---|---|---|---|---|
*In 2013 NSW communities have been designated as “potentially at risk” for the purposes of a mapping exercise †Communities treated without screening in 2013 as per revised guideline instructions |
||||||
At risk* (A) | 80 |
22 |
71 |
10 |
183 |
N/A |
Requiring screening for trachoma (B) | 42 |
22 |
71 |
10 |
145 |
N/A |
Screened for trachoma (C) | 30 |
16 |
71 |
10 |
127 |
15 |
Requiring treatment only (D) | 18 |
N/A |
N/A |
N/A |
18 |
N/A |
Treated† (E) | 17 |
N/A |
N/A |
N/A |
17 |
N/A |
Screened and/or treated for trachoma (F = C+E) | 47 |
16 |
71 |
10 |
144 |
15 |
Requiring neither screening or treatment for trachoma (G=A-B-D) | 20 |
N/A |
N/A |
N/A |
20 |
N/A |
Northern Territory |
South Australia |
Western Australia |
New South Wales |
Total |
Not at risk |
|
---|---|---|---|---|---|---|
*Jurisdictional estimate †In communities that were screened for trachoma |
||||||
Number of communities screened |
30 |
16 |
71 |
10 |
127 |
15 |
Age group (years) | 5-9 |
5-9 |
5-9 |
5-9 |
5-9 |
5-9 |
Children examined for clean face | 1358 |
768 |
1510 |
608 |
4244 |
266 |
Children with clean face | 1057 |
671 |
1112 |
581 |
3421 |
241 |
Clean face prevalence (%) | 78 |
87 |
74 |
96 |
81 |
91 |
Estimated number* of Aboriginal children in communities† | 1681 |
857 |
1684 |
795 |
5017 |
380 |
Children screened for trachoma | 1362 |
768 |
1508 |
575 |
4213 |
265 |
Trachoma screening coverage (%) | 81 |
90 |
90 |
72 |
84 |
70 |
Children with active trachoma | 33 |
27 |
57 |
3 |
120 |
3 |
Active trachoma prevalence (%) | 2.4 |
3.5 |
3.8 |
0.5 |
2.8 |
1.1 |
Active trachoma prevalence using projected data (%) | 5 |
3.5 |
3.8 |
0.5 |
4.0 |
1.1 |
Number of communities |
Northern Territory |
South Australia |
Western Australia |
New South Wales |
Total |
|
---|---|---|---|---|---|---|
*In the NT whole-of-community treatment was guided by the 2014 guidelines. This is defined as the treatment of all people in the community weighing > 3 kg and living in households with children < 15 years of age. In WA and SA whole-of-community treatment was guided by the 2006 guidelines. This is defined as active cases, household contacts and all children in the community aged 6 months to 14 years. | ||||||
Required treatment for trachoma | 34 |
6 |
34 |
1 |
75 |
|
Treated for trachoma | 33 |
6 |
34 |
1 |
74 |
|
Screened and treated | 16 |
6 |
34 |
1 |
57 |
|
Received treatment only | 17 |
N/A |
N/A |
N/A |
17 |
|
Received 6-monthly treatment | 5 |
N/A |
N/A |
N/A |
5 |
|
Did not require treatment | 34 |
10 |
37 |
9 |
90 |
|
Treated active cases and households | 12 |
5 |
27 |
1 |
45 |
|
Treated the whole of community | 21 |
1 |
7 |
0 |
29 |
|
Not treated according to CDNA guidelines | 3 |
0 |
0 |
0 |
3 |
Northern Territory |
South Australia |
Western Australia |
New South Wales |
Total |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
* As per revised guidelines |
|||||||||||||||||||||||||
Age group (years) | 0-4 |
5-9 |
10-14 |
15+ |
All |
0-4 |
5-9 |
10-14 |
15+ |
All |
0-4 |
5-9 |
10-14 |
15+ |
All |
0-4 |
5-9 |
10-14 |
15+ |
All |
0-4 |
5-9 |
10-14 |
15+ |
All |
Active cases requiring treatment | 3 |
33 |
10 |
.. |
46 |
1 |
27 |
5 |
.. |
33 |
15 |
57 |
22 |
.. |
94 |
0 |
3 |
0 |
.. |
3 |
19 |
120 |
37 |
.. |
176 |
Active cases who received treatment | 3 |
33 |
10 |
.. |
46 |
1 |
27 |
5 |
.. |
33 |
15 |
56 |
22 |
.. |
93 |
.. |
3 |
.. |
.. |
3 |
19 |
119 |
37 |
.. |
175 |
Active cases who received treatment (%) | 100 |
100 |
100 |
.. |
100 |
100 |
100 |
100 |
.. |
100 |
100 |
98 |
100 |
.. |
99 |
.. |
100 |
.. |
.. |
100 |
100 |
99 |
100 |
.. |
99 |
Estimated contacts requiring treatment | 1184 |
1497 |
1306 |
7597 |
11584 |
25 |
41 |
29 |
78 |
173 |
102 |
158 |
140 |
317 |
717 |
2 |
3 |
1 |
16 |
22 |
1313 |
1699 |
1476 |
8008 |
12496 |
Number of contacts who received treatment | 1033 |
1297 |
1057 |
5799 |
9186 |
25 |
41 |
28 |
76 |
170 |
81 |
142 |
128 |
315 |
666 |
2 |
3 |
1 |
16 |
22 |
1141 |
1483 |
1214 |
6206 |
10044 |
Estimated contacts who received treatment (%) | 87 |
87 |
81 |
76 |
79 |
100 |
100 |
100 |
97 |
98 |
79 |
90 |
91 |
99 |
93 |
100 |
100 |
100 |
100 |
100 |
87 |
87 |
82 |
77 |
80 |
Total number of doses of azithromycin delivered | 1036 |
1330 |
1067 |
5799 |
9232 |
26 |
68 |
33 |
76 |
203 |
96 |
198 |
150 |
315 |
759 |
2 |
6 |
1 |
16 |
25 |
1160 |
1602 |
1251 |
6206 |
10219 |
Estimated overall treatment coverage (%) | 87 |
87 |
81 |
76 |
79 |
100 |
100 |
97 |
97 |
99 |
82 |
92 |
93 |
99 |
94 |
100 |
100 |
100 |
100 |
100 |
87 |
88 |
83 |
77 |
81 |
Doses administered in communities that were treated without screening* | 423 |
498 |
399 |
2264 |
3584 |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
423 |
498 |
399 |
2264 |
3584 |
Doses administered six-monthly* | 552 |
659 |
574 |
3114 |
4899 |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
.. |
552 |
659 |
574 |
3114 |
4899 |
Northern Territory |
South Australia |
Western Australia |
Total |
||||||
---|---|---|---|---|---|---|---|---|---|
* Population estimate limited to trachoma endemic regions and does not take into account changing endemic regions over time and transiency between regions
† Number of adults examined limited to numbers reported. This number does not account for adults who may be examined in routine adult health checks, and may also include multiple screening | |||||||||
Number of communities screened for trichiasis | 56 |
23 |
64 |
143 |
|||||
Age groups | 15-39 |
40+ |
15-39 |
40+ |
15-39 |
40+ |
15-39 |
40+ |
15+ |
Estimated population in region* | 14087 |
7146 |
3385 |
2121 |
5898 |
3450 |
23370 |
12717 |
36087 |
Adults examined | 1106 |
878 |
512 |
1322 |
161 |
1656 |
1779 |
3856 |
5635 |
With trichiasis (% of adults examined) | 6 (0.05%) |
33 (4%) |
0 |
8 (0.6%) |
0 |
8 (0.5%) |
6 (0.3%) |
49 (1%) |
55 (1%) |
Offered ophthalmic consultation | 0 |
13 |
.. |
8 |
0 |
7 |
0 |
28 |
28 |
Declined ophthalmic consultation | 0 |
2 |
.. |
0 |
0 |
1 |
0 |
3 |
3 |
Surgery in past 12 months | 0 |
23 |
.. |
2 |
0 |
6 |
0 |
31 |
31 |